These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 16794252)
1. Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Kilpatrick LM; Harris RL; Owen KA; Bass R; Ghorayeb C; Bar-Or A; Ellis V Blood; 2006 Oct; 108(8):2616-23. PubMed ID: 16794252 [TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
4. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA. Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. Suzuki M; Kobayashi H; Kanayama N; Saga Y; Suzuki M; Lin CY; Dickson RB; Terao T J Biol Chem; 2004 Apr; 279(15):14899-908. PubMed ID: 14747469 [TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase. Ellis V J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine). Petersen LC Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959 [TBL] [Abstract][Full Text] [Related]
8. Pro-urokinase-type plasminogen activator is a substrate for hepsin. Moran P; Li W; Fan B; Vij R; Eigenbrot C; Kirchhofer D J Biol Chem; 2006 Oct; 281(41):30439-46. PubMed ID: 16908524 [TBL] [Abstract][Full Text] [Related]
9. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen. Ellis V; Whawell SA; Werner F; Deadman JJ Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin). Wang J; Mazar A; Quan N; Schneider A; Henkin J Eur J Biochem; 1997 Jul; 247(1):256-61. PubMed ID: 9249034 [TBL] [Abstract][Full Text] [Related]
11. Regulation of plasminogen activation by human U937 promonocytic cells. Duval-Jobe C; Parmely MJ J Biol Chem; 1994 Aug; 269(33):21353-7. PubMed ID: 8063761 [TBL] [Abstract][Full Text] [Related]
12. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation. Behrendt N; List K; Andreasen PA; Danø K Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347 [TBL] [Abstract][Full Text] [Related]
13. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor. Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580 [TBL] [Abstract][Full Text] [Related]
14. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T; Behrendt N; Ploug M Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652 [TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin. Ellis V; Danø K Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443 [TBL] [Abstract][Full Text] [Related]
16. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT). Reinartz J; Link J; Todd RF; Kramer MD Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643 [TBL] [Abstract][Full Text] [Related]
17. Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system. Behrendt N; Danø K FEBS Lett; 1996 Sep; 393(1):31-6. PubMed ID: 8804418 [TBL] [Abstract][Full Text] [Related]
18. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor. Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039 [TBL] [Abstract][Full Text] [Related]
19. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116 [TBL] [Abstract][Full Text] [Related]
20. Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans. Okumura Y; Hayama M; Takahashi E; Fujiuchi M; Shimabukuro A; Yano M; Kido H Biochem J; 2006 Dec; 400(3):551-61. PubMed ID: 16872279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]